Panagene

Provider of peptide nucleic acid products for diagnostic and therapeutic use

placeDaejeon, Daejeon, South Korea calendar_todayFounded 2001 groups71 employees language panagene.com

Innovation

53 patent families (13 granted) — focus: Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 1,015 times.

YearFilings
20144
20152
20166
20175
20183
20197
20205
20211
20223
20233
20241
20251

Social engagement

Social engagement: 559 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Accelerator & incubator150%

Recent activity

2 Jul 2026
Milestone
Korea Institute of Patent Strategy & Development
18 Jun 2026
Product launch
PANAMutyperTM R EGFR, PANA RealTyperTM, and PANA qPCRTM
11 May 2026
Event
ASGH 2026
Coming soon